Skip to content
10-Q

Quarterly Report

Nuvation Bio Inc. NUVB

0000950170-25-065712

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 25, 2025 340.26M sh
Short Term Debt Q1 2025 · Mar 31, 2025 $5.69M
Short Term Debt Q1 2025 · Dec 31, 2024 $6.28M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $47.98M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $35.72M
Current Liabilities Q1 2025 · Mar 31, 2025 $52.77M
Current Liabilities Q1 2025 · Dec 31, 2024 $58.24M
Total Liabilities Q1 2025 · Mar 31, 2025 $73.03M
Total Liabilities Q1 2025 · Dec 31, 2024 $76.84M
Current Assets Q1 2025 · Mar 31, 2025 $475.57M
Current Assets Q1 2025 · Dec 31, 2024 $526.26M
Total Assets Q1 2025 · Mar 31, 2025 $492.49M
Total Assets Q1 2025 · Dec 31, 2024 $540.63M
Gross Profit Q1 2025 · Mar 31, 2025 $990K
Gross Profit Q1 2025 · Mar 31, 2024 $0
Cost Of Revenue Q1 2025 · Mar 31, 2025 $2.09M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $0
Shares Diluted Q1 2025 · Mar 31, 2024 219.05K sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$15.7M
Stockholders Equity Q1 2025 · Mar 31, 2024 $594.04M
Stockholders Equity Q1 2025 · Dec 31, 2023 $605.12M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.07
Eps Basic Q1 2025 · Mar 31, 2024 −$0.07
Sga Expense Q1 2025 · Mar 31, 2024 $7.36M
Rd Expense Q1 2025 · Mar 31, 2024 $12.84M
Net Income Q1 2025 · Mar 31, 2024 −$14.79M
Operating Income Q1 2025 · Mar 31, 2024 −$20.2M
Revenue Q1 2025 · Mar 31, 2024 $0